“it considerably reduces the effects of certain diseases”, notes Damien Mascret, health journalist and doctor

The experimentation with therapeutic cannabis, launched in 2020 in France, has been extended. But from Wednesday March 27, it will no longer be possible to be included in this study. The doctor and health journalist Damien Mascret, explains in 12/13 info, Tuesday March 26, that “we’re going to be one ‘no man’s land’ until December”, but that “those who already have medical cannabis will continue to have it”. “From 2025 (…) some patients may benefit from it”he adds.

A considerable effect on “neuropathic pain”

Regarding the effectiveness of the treatment, “that works (…) vsFor certain patients, it considerably reduces the effects of their illness., underlines Damien Mascret. And especially “neuropathic pain”points out the doctor, listing their effects: “burning, tingling, insensitivity”. Pains that touched “more than half of the patients included in the experiment” and could concern “up to 7% of French people”further indicates the specialist in health issues.

According to Damien Mascret, “unbearable pain, which at the start of the study affected 80%” patients, have moved to “30% after three months”. “Oncology, or paliative care”are also part of the indications for this type of treatment.